Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

10 Feb 2017 07:00

RNS Number : 5406W
S & U PLC
10 February 2017
 

 10th February 2017

 

 

S&U plc

("S&U", "the Company" or "the Group")

 

YEAR END TRADING UPDATE

 

 

S&U plc, the motor finance and specialist lender, today issues a trading update for the period from its Trading Statement of the 8th December 2016 to the Company's year-end on the 31st January 2017.

 

The Company is again pleased to announce that trading has remained strong and in line with market expectations; its final results will be announced on 28th March 2017.

 

Current Trading

 

Advantage Finance, our motor finance business, finished a record year very strongly. Cash collections in the period exceeded a buoyant 2016 by 31%, whilst both transaction numbers and loan advances comfortably beat last year. This year Advantage achieved 20,000 new transactions for the first time, beating the previous record by nearly 5,000 deals; it now has a record 43,000 live customers.

 

Loan quality remains good and, as reported in our last Trading Statement, is both stable and within our expectations. This fully justifies the additional £33million invested in the business in the year just ended.

 

Within the last quarter, Advantage has received confirmation of its full licence authorisation from the FCA and has continued to introduce further refinements to its renowned underwriting and book analysis capabilities. 

 

Aspen Bridging

 

As anticipated in December, our Aspen bridging finance operation has now received all necessary approvals, and we are pleased to announce it has now opened for business. We confidently expect a successful pilot over the next fifteen months.

 

Funding and Treasury

 

At the year end the Group has borrowings of £49m allowing good headroom within our total committed facilities of £85m. We anticipate concluding further loan facilities as our businesses require.

 

Dividend

 

The Group's current trading and future prospects have led to your Board approving a second interim dividend of 28p per ordinary share (2016: 23p). This will be payable on 17th March 2017 to holders on the share register on the 24th February 2017. Together with the first dividend paid in November of 24p per share this will total 52p per share against 43p last year and 36p two years ago. These increases are consistent with our aim of returning to twice covered dividends over time.

 

 

 

 

Commenting on the Group trading and outlook, Anthony Coombs, Chairman of S&U PLC said:

 

"Within a robust domestic economy, a stable regulatory environment and a competitive market, we are confident in the Group's ability to continue to grow at a consistent and sustainable rate, and in the shareholder value that implies."

For further information, please contact:

 

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777

 

Broker & Financial Advisor

Chris Hardie Arden Partners 0207 614 5917

 

Media and Investor Relations

Ged Brumby Smithfield 0207 903 0674

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDDISGBGRC
Date   Source Headline
9th Apr 20217:00 amEQSEdison Investment Research Limited: S&U (SUS): Ready to meet unlocked demand
30th Mar 20217:00 amRNSPreliminary Results
18th Mar 20217:00 amRNSInvestor Presentation
11th Feb 202110:00 amRNSCORRECTION: TRADING STATEMENT & NOTICE OF RESULTS
11th Feb 20217:00 amRNSTrading Statement and Notice of Results
27th Jan 20213:40 pmRNSDirector/PDMR Shareholding
9th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSTrading Statement
23rd Nov 20209:55 amRNSBlock Listing Six Monthly Return
30th Sep 20207:01 amRNSDirectorate Change
30th Sep 20207:00 amRNSInterim Results
24th Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSNotice of Results
28th Aug 20203:36 pmRNSHolding(s) in Company
28th Aug 20203:35 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
31st Jul 20203:06 pmRNSTotal Voting Rights
30th Jun 20205:47 pmRNSTotal Voting Rights
9th Jun 20201:10 pmRNSResult of AGM
9th Jun 20207:00 amRNSAGM Statement and Trading Update
1st Jun 202010:25 amRNSTotal Voting Rights
22nd May 20209:35 amRNSBlock Listing Six Monthly Return
13th May 202012:50 pmRNSDirector/PDMR Shareholding
6th May 20202:00 pmRNSAnnual Report and Accounts
1st May 20207:00 amRNSTotal Voting Rights
15th Apr 20204:55 pmRNSBlock Listing Application
9th Apr 20204:42 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20202:04 pmRNSPreliminary Results: Replacement
8th Apr 20207:00 amRNSPreliminary Results
6th Apr 20207:00 amRNSNotice of Results
23rd Mar 20207:00 amRNSDelay to Publication of Full Year Results
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20204:41 pmRNSSecond Price Monitoring Extn
20th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20207:00 amRNSTrading Statement and Notice of Results
7th Jan 20203:19 pmRNSExercise and Sale of Options, Total Voting Rights
18th Dec 20195:40 pmRNSExercise and Sale of Options, Total Voting Rights
10th Dec 20197:00 amRNSTrading Statement
2nd Dec 20192:42 pmRNSBlock listing Six Monthly Return
23rd Oct 20193:38 pmRNSExercise and Sale of Options & Total Voting Rights
22nd Oct 20192:00 pmRNSExercise and Sale of Options & Total Voting Rights
17th Oct 20194:55 pmRNSExercise of Options and Total Voting Rights
24th Sep 20197:01 amRNSAppointment by Advantage Finance of New CEO
24th Sep 20197:00 amRNSInterim Results
15th Aug 201912:08 pmRNSSecond Price Monitoring Extn
15th Aug 201912:02 pmRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSTrading Update and Notice of Results
1st Aug 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.